Retention and Predictors of Attrition Among HIV-infected Children on Antiretroviral Therapy in Cote d'Ivoire Between 2012 and 2016

被引:0
|
作者
Toure, Fatoumata [1 ]
Etheredge, Gina D. [2 ]
Brennan, Claire [3 ]
Parris, KaeAnne [4 ]
Diallo, Mamadou Otto [5 ]
Ouffoue, Ange Fulgence [6 ]
Ekra, Alexandre [7 ]
Prao, Herve [7 ]
Assamoua, N'Da Viviane [8 ]
Gnongoue, Christian [9 ]
Kone, Foungnigue [8 ]
Koffi, Christian [8 ]
Kamagate, Fathim [7 ]
Rivadeneira, Emilia [4 ]
Carpenter, Deborah [4 ]
机构
[1] FHI 360, Global Hlth & Populat Business Unit, Abidjan, Cote Ivoire
[2] FHI 360, Global Hlth & Populat Business Unit, Washington, DC USA
[3] US Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA USA
[4] RTI, Food Secur & Agr Div, Durham, NC USA
[5] US Ctr Dis Control & Prevent, USAID, US Presidents Malaria Initiat PMI, Monrovia, Liberia
[6] MSH, Programme MTaPS, Abidjan, Cote Ivoire
[7] US Ctr Dis Control & Prevent, Div Global HIV & TB, Abidjan, Cote Ivoire
[8] Programme Natl Lutte Sida PNLS, Serv Rech, Abidjan, Cote Ivoire
[9] ITECH UW, Dept Global Hlth, Abidjan, Cote Ivoire
关键词
HIV; pediatric; ART; retention; attrition; FOLLOW-UP; CARE; INTERVENTIONS; LINKAGE; PROGRAM;
D O I
10.1097/INF.0000000000003839
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background:An estimated 21,000 children 0-14 years of age were living with HIV in Cote d'Ivoire in 2020, of whom only 49% have been diagnosed and are receiving antiretroviral therapy (ART). Retention in HIV care and treatment is key to optimize clinical outcomes. We evaluated pediatric retention in select care and treatment centers (CTCs) in Cote d'Ivoire. Methods:We retrospectively reviewed medical records using 2-stage cluster sampling for children under 15 years initiated on ART between 2012 and 2016. Kaplan-Meier time-to-event analysis was done to estimate cumulative attrition rates per total person-years of observation. Cox proportional hazard regression was performed to identify factors associated with attrition. Results:A total of 1198 patient records from 33 CTCs were reviewed. Retention at 12, 24, 36, 48 and 60 months after ART initiation was 91%, 84%, 74%, 72% and 70%, respectively. A total of 309 attrition events occurred over 3169 person-years of follow-up [266 children were lost to follow-up (LTFU), 29 transferred to another facility and 14 died]. LTFU determinants included attending a "public-private" CTC [adjusted hazard ratio (aHR) 6.05; 95% confidence interval (CI): 4.23-8.65], receiving care at a CTC without an on-site laboratory (aHR: 4.01; 95% CI: 1.70-9.46) or attending a CTC without an electronic medical record (EMR) system (aHR: 2.22; 95% CI: 1.59-3.12). Conclusions:In Cote d'Ivoire, patients attending a CTC that is public-private, does not have on-site laboratory or EMR system were likely to be LTFU. Decentralization of laboratory services and scaling use of EMR systems could help to improve pediatric retention.
引用
收藏
页码:299 / 304
页数:6
相关论文
共 50 条
  • [41] Predictors of growth and body composition in HIV-infected children beginning or changing antiretroviral therapy
    Chantry, C. J.
    Cervia, J. S.
    Hughes, M. D.
    Alvero, C.
    Hodge, J.
    Borum, P.
    Moye, J., Jr.
    HIV MEDICINE, 2010, 11 (09) : 573 - 583
  • [42] Hospitalization for severe malnutrition among HIV-infected children starting antiretroviral therapy
    Prendergast, Andrew
    Bwakura-Dangarembizi, Mutsa F.
    Cook, Adrian D.
    Bakeera-Kitaka, Sabrina
    Natukunda, Eva
    Ntege, Patricia Nahirya
    Nathoo, Kusum J.
    Karungi, Christine
    Lutaakome, Joseph
    Kekitiinwa, Adeodata
    Gibb, Diana M.
    AIDS, 2011, 25 (07) : 951 - 956
  • [43] Safety and Tolerability of Antiretroviral Therapy Among HIV-Infected Children And Adolescents In UGANDA
    Tukei, Vincent J.
    Asiimwe, Alice
    Maganda, Albert
    Atugonza, Rita
    Sebuliba, Isaac
    Bakeera-Kitaka, Sabrina
    Musoke, Phillipa
    Kalyesubula, Israel
    Kekitiinwa, Adeodata
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 59 (03) : 274 - 280
  • [44] Virologic and immunologic response to antiretroviral therapy and predictors of HIV type 1 drug resistance in children receiving treatment in Abidjan, Cote d'Ivoire
    Adje-Toure, Christiane
    Hanson, Debra L.
    Talla-Nzussouo, N.
    Borget, Marie-Yolande
    Kouadio, Leonard Ya
    Tossou, Odette
    Fassinou, Patricia
    Bissagnene, Emmanuel
    Kadio, Auguste
    Nolan, Monica L.
    Nkengasong, John N.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 (07) : 911 - 917
  • [45] Adherence with antiretroviral therapy in HIV-infected children.
    Schuval, SJ
    DeSarbo, J
    Mamonluk, M
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) : S214 - S214
  • [46] Progress and challenges in antiretroviral therapy for HIV-infected children
    Rosenberg M.G.
    Abadi J.
    Dobroszycki J.
    Wiznia A.
    Current Infectious Disease Reports, 2006, 8 (4) : 324 - 331
  • [47] Adherence to antiretroviral therapy in HIV-infected children in Italy
    Albano, F
    Spagnuolo, MI
    Canani, RB
    Guarino, A
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 1999, 11 (06): : 711 - 714
  • [48] Delays in Initiation of Antiretroviral Therapy Among HIV-infected Children in Rural Zambia
    Sutcliffe, Catherine G.
    van Dijk, Janneke H.
    Muleka, Mathias
    Munsanje, Jeridy
    Thuma, Philip E.
    Moss, William J.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (04) : E107 - E112
  • [49] Hepatotoxicity in HIV-infected children and adolescents on antiretroviral therapy
    Mantes Gil, Am Cecilia
    Lorenzetti, Raquel
    Mendes, Gun Bergsten
    Morcillo, Andre Moreno
    Dalbo Contreras Toro, Adyleia Aparecida
    Nolasco do Silva, Marcos Tadeu
    dos Santos Vilela, Maria Marluce
    SAO PAULO MEDICAL JOURNAL, 2007, 125 (04): : 205 - 209
  • [50] Guideline for Antiretroviral Therapy of HIV-Infected Children and Adolescents
    Neubert, J.
    Niehues, T.
    Baumann, U.
    Buchholz, B.
    Notheiss, G.
    Wintergerst, U.
    Blume, J.
    Feiterna-Sperling, C.
    Laws, H. -J
    Linde, R.
    Koenigs, C.
    KLINISCHE PADIATRIE, 2012, 224 (02): : 98 - 110